Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
Main Authors: | Seung Min Lee, Dae Won Jun |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2023-01-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2022-0381.pdf |
Similar Items
-
Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
by: Yuanbin Liu, et al.
Published: (2023-01-01) -
Auranofin-Mediated NRF2 Induction Attenuates Interleukin 1 Beta Expression in Alveolar Macrophages
by: Stephanie B. Wall, et al.
Published: (2021-04-01) -
Antileishmanial activity of auranofin against Leishmania major in vitro
by: Mohammad Ezati Mehmandust Olya, et al.
Published: (2022-01-01) -
Gold(I) ion and the phosphine ligand are necessary for the anti-Toxoplasma gondii activity of auranofin
by: C. I. Ma, et al.
Published: (2024-02-01) -
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study
by: Damiano Cirri, et al.
Published: (2021-05-01)